While most cancers are clinically challenging, brain tumors represent a particularly intractable group, and within pediatric brain tumors, structural variants (SVs) play an important role. In this webinar, Dr. Miriam Bornhorst, from Children’s National Hospital, shares her research aimed at finding a more reliable approach for detection of SVs in pediatric brain tumor samples. Dr. Bornhorst’ shares her experience with OGM as an effective method for the identification of clinically relevant SVs, some of which are not detected with other clinical testing methods.